Harvey Investment CO LLC Abbott Laboratories Transaction History

Harvey Investment CO LLC

$886 Million
Q3 2024

A detailed history of Harvey Investment CO LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Harvey Investment CO LLC holds 243,635 shares of ABT stock, worth $28.2 Million. This represents 3.14% of its overall portfolio holdings.

Number of Shares

243,635

Previous 231,585 5.2%

Holding current value

$28.2 Million

Previous $24.1 Million 15.43%

% of portfolio

3.14%

Previous 2.88%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$100.07 - $118.13 $1.21 Million - $1.42 Million	12,050 Added 5.2%	243,635 $27.8 Million
Q2 2024 Jul 23, 2024	BUY	$100.73 - $112.44 $198,438 - $221,506	1,970 Added 0.86%	231,585 $24.1 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $327,464 - $361,670	-2,990 Reduced 1.29%	229,615 $26.1 Million
Q4 2023 Jan 24, 2024	BUY	$90.19 - $110.4 $217,357 - $266,064	2,410 Added 1.05%	232,605 $25.6 Million
Q3 2023 Oct 18, 2023	SELL	$95.53 - $114.62 $92,568 - $111,066	-969 Reduced 0.42%	230,195 $22.3 Million
Q2 2023 Jul 25, 2023	SELL	$100.78 - $112.29 $20,659 - $23,019	-205 Reduced 0.09%	231,164 $25.2 Million
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $805,390 - $947,993	8,315 Added 3.73%	231,369 $23.4 Million
Q4 2022 Jan 20, 2023	SELL	$95.06 - $111.52 $118,539 - $139,065	-1,247 Reduced 0.56%	223,054 $24.5 Million
Q3 2022 Oct 17, 2022	SELL	$96.76 - $112.03 $11,417 - $13,219	-118 Reduced 0.05%	224,301 $21.7 Million
Q2 2022 Jul 19, 2022	SELL	$102.07 - $123.37 $49,503 - $59,834	-485 Reduced 0.22%	224,419 $24.4 Million
Q1 2022 Apr 20, 2022	SELL	$114.02 - $139.04 $45,608 - $55,616	-400 Reduced 0.18%	224,904 $26.6 Million
Q4 2021 Jan 20, 2022	SELL	$115.53 - $141.46 $204,141 - $249,959	-1,767 Reduced 0.78%	225,304 $31.7 Million
Q3 2021 Nov 02, 2021	SELL	$116.66 - $129.06 $43,747 - $48,397	-375 Reduced 0.16%	227,071 $26.8 Million
Q2 2021 Jul 23, 2021	BUY	$105.79 - $124.53 $156,569 - $184,304	1,480 Added 0.65%	227,446 $26.4 Million
Q1 2021 Apr 22, 2021	SELL	$108.84 - $128.23 $610,592 - $719,370	-5,610 Reduced 2.42%	225,966 $27.1 Million
Q4 2020 Jan 21, 2021	SELL	$105.0 - $114.42 $84,945 - $92,565	-809 Reduced 0.35%	231,576 $25.4 Million
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $11,913 - $14,467	130 Added 0.06%	232,385 $25.3 Million
Q2 2020 Jul 17, 2020	SELL	$76.57 - $98.0 $447,934 - $573,300	-5,850 Reduced 2.46%	232,255 $21.2 Million
Q1 2020 Apr 21, 2020	SELL	$62.82 - $91.86 $296,196 - $433,119	-4,715 Reduced 1.94%	238,105 $18.8 Million
Q4 2019 Jan 28, 2020	SELL	$78.51 - $87.4 $47,106 - $52,440	-600 Reduced 0.25%	242,820 $21.1 Million
Q3 2019 Oct 21, 2019	SELL	$81.84 - $88.74 $44,520 - $48,274	-544 Reduced 0.22%	243,420 $20.4 Million
Q2 2019 Jul 16, 2019	SELL	$72.88 - $85.0 $18,948 - $22,100	-260 Reduced 0.11%	243,964 $20.5 Million
Q1 2019 Apr 11, 2019	SELL	$66.22 - $80.06 $421,225 - $509,261	-6,361 Reduced 2.54%	244,224 $19.5 Million
Q4 2018 Jan 31, 2019	BUY	$65.56 - $74.27 $131,775 - $149,282	2,010 Added 0.81%	250,585 $18.1 Million
Q3 2018 Oct 22, 2018	BUY	$60.81 - $73.36 $146,552 - $176,797	2,410 Added 0.98%	248,575 $18.2 Million
Q2 2018 Jul 24, 2018	SELL	$57.57 - $63.54 $35,290 - $38,950	-613 Reduced 0.25%	246,165 $15 Million
Q1 2018 Apr 23, 2018	BUY	$56.27 - $63.62 $326,984 - $369,695	5,811 Added 2.41%	246,778 $14.8 Million
Q4 2017 Jan 29, 2018	SELL	$53.68 - $57.47 $141,715 - $151,720	-2,640 Reduced 1.08%	240,967 $13.8 Million
Q3 2017 Oct 18, 2017	BUY	$48.06 - $53.64 $11.7 Million - $13.1 Million	243,607	243,607 $13 Million

Others Institutions Holding ABT

# of Institutions

3,187

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harvey Investment CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harvey Investment CO LLC with notifications on news.

Account

Harvey Investment CO LLC Abbott Laboratories Transaction History